JPS54160745A - Circulatory disease treating agent - Google Patents

Circulatory disease treating agent

Info

Publication number
JPS54160745A
JPS54160745A JP6790178A JP6790178A JPS54160745A JP S54160745 A JPS54160745 A JP S54160745A JP 6790178 A JP6790178 A JP 6790178A JP 6790178 A JP6790178 A JP 6790178A JP S54160745 A JPS54160745 A JP S54160745A
Authority
JP
Japan
Prior art keywords
treating agent
circulatory disease
disease treating
circulatory
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6790178A
Other languages
Japanese (ja)
Inventor
Haruo Oonishi
Suguru Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP6790178A priority Critical patent/JPS54160745A/en
Priority to GB7918840A priority patent/GB2026861B/en
Priority to DE19792922478 priority patent/DE2922478A1/en
Priority to FR7914149A priority patent/FR2427822A1/en
Publication of JPS54160745A publication Critical patent/JPS54160745A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP6790178A 1978-06-06 1978-06-06 Circulatory disease treating agent Pending JPS54160745A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP6790178A JPS54160745A (en) 1978-06-06 1978-06-06 Circulatory disease treating agent
GB7918840A GB2026861B (en) 1978-06-06 1979-05-30 Pharmaceutical compositions containing 5-methyl-7-diethylamino-s-triazolo (1,5- )-pyrimidine
DE19792922478 DE2922478A1 (en) 1978-06-06 1979-06-01 MEDICINAL PRODUCTS FOR TREATMENT OF CIRCULAR DISEASES
FR7914149A FR2427822A1 (en) 1978-06-06 1979-06-01 MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6790178A JPS54160745A (en) 1978-06-06 1978-06-06 Circulatory disease treating agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1087883A Division JPS58192823A (en) 1983-01-26 1983-01-26 Serum cholesterol depressant

Publications (1)

Publication Number Publication Date
JPS54160745A true JPS54160745A (en) 1979-12-19

Family

ID=13358252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6790178A Pending JPS54160745A (en) 1978-06-06 1978-06-06 Circulatory disease treating agent

Country Status (4)

Country Link
JP (1) JPS54160745A (en)
DE (1) DE2922478A1 (en)
FR (1) FR2427822A1 (en)
GB (1) GB2026861B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681517A (en) * 1979-12-07 1981-07-03 Mochida Pharmaceut Co Ltd Drug having inhibiting action of thromboxane a2
JPS56104818A (en) * 1980-01-24 1981-08-20 Mochida Pharmaceut Co Ltd Pharmaceutical composition having cerebral and peripheral blood flow improving activity
WO1985004172A1 (en) * 1984-03-12 1985-09-26 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681517A (en) * 1979-12-07 1981-07-03 Mochida Pharmaceut Co Ltd Drug having inhibiting action of thromboxane a2
JPS6232721B2 (en) * 1979-12-07 1987-07-16 Mochida Pharm Co Ltd
JPS56104818A (en) * 1980-01-24 1981-08-20 Mochida Pharmaceut Co Ltd Pharmaceutical composition having cerebral and peripheral blood flow improving activity
WO1985004172A1 (en) * 1984-03-12 1985-09-26 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition

Also Published As

Publication number Publication date
DE2922478A1 (en) 1979-12-13
GB2026861A (en) 1980-02-13
FR2427822B1 (en) 1983-08-26
FR2427822A1 (en) 1980-01-04
GB2026861B (en) 1983-04-27

Similar Documents

Publication Publication Date Title
JPS54113409A (en) Treating agent for hyperlipoid disease
JPS54113442A (en) Treating agent of hyperlipoid disease
JPS54151131A (en) Treating agent for kidney disease
GB2075816B (en) Crop treatment
GB2014555B (en) Water treatment
JPS55136227A (en) Peripheral vessel disease treating agent
ZA793755B (en) Skin treatment compositions
GB2018134A (en) Cerebral therapeutic agent
ZA796708B (en) Therapeutic agents
JPS5547870A (en) Medical treatment method
JPS5396329A (en) Treating agent for dry skin disease
GB2026060B (en) Well treatment
ZA792390B (en) Therapeutic agents
GB2013181B (en) Therapeutic agents
GB2019836B (en) Therapeutic agents
JPS54140714A (en) Skin treating composition
JPS54135210A (en) Tumor treating agent
JPS54160745A (en) Circulatory disease treating agent
JPS5547251A (en) Solidification treating agent
GB2011890B (en) Therapeutic agents
JPS5588769A (en) Compound blood treating device
JPS54136576A (en) Solution treatment
GB2011891B (en) Therapeutic agents
GB2013179B (en) Therapeutic agents
JPS54145216A (en) Plant disease controlling agent